ClinicalTrials.Veeva
Menu

Find clinical trials for Diabetes in Budapest, Budapest

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Type 2 Diabetes Mellitus
Diabetes Mellitus
Obesity
Type 1 Diabetes Mellitus
Diabetic Foot
Overweight
Foot Ulcer

Diabetes trials near Budapest, Budapest, HUN:

A Phase III Study to Investigate if the Study Drug Diamyd Can Preserve Insulin Production and Improve Glycemic Control in Patients Newly Diagnosed With Type 1 Diabetes (DIAGNODE-3)

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd also known as retogatein compared...

Active, not recruiting
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Budapest, Hungary and 59 other locations

The primary objective of this study is to demonstrate that maridebart cafraglutide is superior to placebo for percent change in body weight.

Active, not recruiting
Type 2 Diabetes Mellitus (T2DM), Obesity, Overweight
Drug: Maridebart cafraglutide
Drug: Placebo

Phase 3

Amgen
Amgen

Budapest, Hungary and 187 other locations

This study will look at how much cagrilintide helps people with overweight or obesity and type 2 diabetes lower their body weight. Cagrilint...

Active, not recruiting
Type 2 Diabetes
Overweight
Drug: Cagrilintide
Drug: Placebo (matched to Cagrilintide)

Phase 3

Novo Nordisk
Novo Nordisk

Komárom, Hungary and 66 other locations

effective for treating people who have excess body weight and type 2 diabetes. There are 2 study treatments in this study taken as injection...

Enrolling
Diabetes Mellitus
Overweight
Drug: NNC0487-0111
Drug: Placebo (matched to NNC0487-0111)

Phase 3

Novo Nordisk
Novo Nordisk

Budapest, Hungary and 72 other locations

Phase II study aims to evaluate the efficacy, tolerability, and safety of RO7795081 for glycemic control in adult participants with Type 2 diabetes...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Semaglutide
Drug: Placebo

Phase 2

Roche
Roche

Budapest, Hungary and 50 other locations

effective for treating people who have excess body weight and type 2 diabetes. Participant will receive 2 injections every week: an active m...

Begins enrollment this month
Diabetes Mellitus, Type 2
Overweight
Drug: Placebo (matched to semaglutide)
Drug: NNC0487-0111

Phase 3

Novo Nordisk
Novo Nordisk

Komárom, Komárom-Esztergom, Hungary and 119 other locations

This clinical study is testing how the study medicine CagriSema helps people living with obesity, with or without type 2 diabetes (T2D), los...

Begins enrollment this month
Type 2 Diabetes
Obesity
Drug: Cagrisema
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Budapest, Hungary and 301 other locations

Locations recently updated

This study will look at how much CagriSema lowers blood sugar and body weight in people with type 2 diabetes. CagriSema is a new investigati...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Cagrilintide
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Budapest, Hungary and 165 other locations

Parallel-group, Multicenter Clinical Study to Evaluate the Efficacy and Safety of AVT29 Compared with Eylea HD in Participants with Diabetic...

Enrolling
Diabetic Macular Edema
Drug: AVT29 (proposed aflibercept HD biosimilar)
Drug: Eylea HD (aflibercept HD)

Phase 3

Alvotech

Budapest, Hungary

This study is open to adults with diabetic retinopathy. People who have non-proliferative diabetic retinopathy of moderate or high ...

Active, not recruiting
Diabetic Retinopathy
Drug: BI 764524
Drug: Aflibercept (Eylea®) - US only

Phase 2

Boehringer Ingelheim
Boehringer Ingelheim

Budapest, Hungary and 89 other locations

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems